Now showing items 1-2 of 2

    • A refinement of clinical tumor marker monitoring: Why not use an inverse value of doubling time? 

      Zaleskis, Gintaras; Bosas, Paulius; Ulys, Albertas; Dabkevičienė, Daiva; Darulytė, Neringa; Hudson, Bret Andrew; Pašukonienė, Vita (Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2021)
      OBJECTIVES: The aim of this study was to compare prostate-specific antigen (PSA) kinetics - half-life time (HT), doubling time (DT), and elimination rate PSA (ePSA) in prostate cancer (PCa) monitoring. Implementation of ...
    • Immunophenotype rearrangement in response to tumor excision may be related to the risk of biochemical recurrence in prostate cancer patients 

      Bosas, Paulius; Zaleskis, Gintaras; Dabkevičienė, Daiva; Darulytė, Neringa; Mlynska, Agata; Tikuišis, Renatas; Ulys, Albertas; Pašukonienė, Vita; Jarmalaitė, Sonata; Jankevičius, Feliksas (Journal of clinical medicine: Special Issue Recent Advances in Prostate Cancer Treatment, 2021)
      BACKGROUND: Prostate cancer (PCa) is known to exhibit a wide spectrum of aggressiveness and relatively high immunogenicity. The aim of this study was to examine the effect of tumor excision on immunophenotype rearrangements ...